In right now’s quickly altering and extremely aggressive enterprise world, it’s critical for traders and business fanatics to fastidiously assess corporations. On this article, we’ll carry out a complete business comparability, evaluating UnitedHealth Group UNH towards its key opponents within the Well being Care Suppliers & Providers business. By analyzing essential monetary metrics, market place, and progress prospects, we purpose to supply useful insights for traders and make clear firm’s efficiency inside the business.
UnitedHealth Group Background
UnitedHealth Group is among the largest personal well being insurers, offering medical advantages to about 50 million members globally, together with 1 million exterior the us as June 2024. As a pacesetter in employer-sponsored, self-directed, and government-backed insurance coverage, UnitedHealth has obtained huge scale in managed care. Together with its insurance coverage property, UnitedHealth’s continued investments in its Optum franchises have created a healthcare companies colossus that spans all the pieces from medical and pharmaceutical advantages to offering outpatient care and analytics to each affiliated and third-party prospects.
| Firm | P/E | P/B | P/S | ROE | EBITDA (in billions) | Gross Revenue (in billions) | Income Development |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group Inc | 34.10 | 5.11 | 1.25 | 6.59% | $9.73 | $21.39 | 8.55% |
| Molina Healthcare Inc | 15.21 | 3.59 | 0.44 | 6.78% | $0.51 | $1.19 | 20.96% |
| Progyny Inc | 30.42 | 3.57 | 1.56 | 2.34% | $0.01 | $0.06 | 2.04% |
| Common | 22.82 | 3.58 | 1.0 | 4.56% | $0.26 | $0.62 | 11.5% |
By conducting an in-depth evaluation of UnitedHealth Group, we will establish the next tendencies:
The Value to Earnings ratio of 34.1 for this firm is 1.49x above the business common, indicating a premium valuation related to the inventory.
The elevated Value to E book ratio of 5.11 relative to the business common by 1.43x suggests firm may be overvalued based mostly on its ebook worth.
With a comparatively excessive Value to Gross sales ratio of 1.25, which is 1.25x the business common, the inventory may be thought of overvalued based mostly on gross sales efficiency.
The corporate has a better Return on Fairness (ROE) of 6.59%, which is 2.03% above the business common. This implies environment friendly use of fairness to generate income and demonstrates profitability and progress potential.
The corporate displays larger Earnings Earlier than Curiosity, Taxes, Depreciation, and Amortization (EBITDA) of $9.73 Billion, which is 37.42x above the business common, implying stronger profitability and sturdy money stream technology.
With larger gross revenue of $21.39 Billion, which signifies 34.5x above the business common, the corporate demonstrates stronger profitability and better earnings from its core operations.
The corporate is witnessing a considerable decline in income progress, with a fee of 8.55% in comparison with the business common of 11.5%, which signifies a difficult gross sales setting.
Debt To Fairness Ratio
The debt-to-equity (D/E) ratio offers insights into the proportion of debt an organization has in relation to its fairness and asset worth.
Contemplating the debt-to-equity ratio in business comparisons permits for a concise analysis of an organization’s monetary well being and danger profile, aiding in knowledgeable decision-making.
In mild of the Debt-to-Fairness ratio, a comparability between UnitedHealth Group and its prime 4 friends reveals the next data:
Amongst its prime 4 friends, UnitedHealth Group has a better debt-to-equity ratio of 0.83.
This implies a higher reliance on debt financing, which may expose the corporate to elevated monetary danger and potential volatility.
Key Takeaways
For UnitedHealth Group, the PE, PB, and PS ratios are all excessive in comparison with its friends within the Well being Care Suppliers & Providers business, indicating doubtlessly overvalued inventory. However, the excessive ROE, EBITDA, and gross revenue recommend sturdy profitability and operational effectivity. Nevertheless, the low income progress fee could increase issues in regards to the firm’s future efficiency relative to its business opponents.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
Overview Score:
Speculative
Market Information and Information dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.

